Enchem Acquires 11th Series Convertible Bond Worth 943 Million KRW Before Maturity, Potential Dilution Relief If Canceled
Enchem used its own funds of approximately 943 million KRW to acquire all of its 11th series unregistered unsecured private convertible bonds before maturity via over-the-counter purchase. This action was taken in agreement with the bondholder, and the acquired bonds have a total face value of 800 million KRW, which the company plans to either resell or cancel through a board resolution.
The conversion price of these bonds is 73,305 KRW per share, representing approximately 10,914 shares upon full conversion, equivalent to only 0.05% of total outstanding shares of 21,910,993. Therefore, the dilution impact is negligible and the capital dilution score is neutral.
The use of funds is defensive in nature, aimed at eliminating potential conversion rights early rather than repaying existing debt. If the bonds are canceled, capital efficiency may slightly improve. The counterparty is the existing bondholder, presenting low credit risk.
[AI Summary]Enchem's early acquisition of its 11th series convertible bond totaling 943 million KRW is a minor capital adjustment with limited impact on the stock price. Potential dilution is negligible at 0.05% of shares outstanding, and cancellation would be mildly positive while resale would be neutral.
KOSDAQ Filing Information
Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity After Issuance (11th Series)